See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2012_United_Therapeutics_Corp.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001082554, United Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 562,455,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 366,046,000 |
| 3 | remainder_Assets | 589,578,000 |
| 4 | LiabilitiesCurrent | 212,577,000 |
| 5 | LiabilitiesNoncurrent | 80,500,000 |
| 6 | remainder_Liabilities | 265,632,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 156,482,000 |
| 9 | ResearchAndDevelopmentExpense | 180,015,000 |
| 10 | remainder_Expenses | 170,778,000 |
| 11 | remainder_Revenues | 743,183,000 |
| 12 | remainder_NetIncome | -18,665,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,518,079,000 |
| 1 | Liabilities | 558,709,000 |
| 2 | Expenses | 507,275,000 |
| 3 | Revenues | 743,183,000 |
| 4 | StockholdersEquity | 959,370,000 |
| 5 | NetIncome | 217,243,000 |
| 6 | ComprehensiveNetIncome | 217,243,000 |
| 7 | BaseVar | 1,672,955,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.22 |
| 9 | EconomicCapitalRatio | 3.17 |
Edgar->Model Mapping
Feature Distribution
Change over Time
